Controversies 2019 Online Syllabus
General Course Materials
To the best of our ability, PDFs of the faculty presentations will be posted below within 24 hours of presentation when approved by the speaker. Refresh this page daily to see the newest additions to the presentations.
Thursday, November 14, 2019
Session I: Atherosclerosis and Dyslipidemia
GUT Heart Axis: Potential Therapeutic Implications
W.H. Wilson Tang, MD, FACC
Aspirin in Primary Prevention: Who Should Get It?
Sanjay Kaul, MD, MPH, FACC
Targeting ANGPTL3 In Hyperlipidemia
P.K. Shah, MD, MACC
Keynote Lecture: Comprehensive Imaging in Heart Failure
Jeroen Bax, MD, PhD, FACC
Session II: Digital Medicine
Healthcare in the Age of Disruption
Raj Khandwalla, MD, MA, FACC
ACC Initiatives
John G. Harold, MD, MACC
Keynote Lecture: The Hospital Readmission Reduction Policy and Population Health in Heart Failure
Gregg Fonarow, MD, FACC
The Future of Healthcare Delivery
Sachin Jain, MD, FACC
Session III: Controversies in the Treatment of CAD: Expert Views
Complete Versus Incomplete Revascularization in STEMI and MV Disease: Is There Still a Debate?
Shamir Mehta, MD, MSc, FACC
State-of-the-Art: Optimal DAPT Strategies: Lessons Learned, Global Leaders, TWIGHLIGHT, and More
Roxana Mehran, MD, FACC
PCI in Selected Cases: EXCEL, NOBLE and Even Long Term SYNTAXES Show Similar Results
Roxana Mehran, MD, FACC
CABG in All Cases: More Durable, Better Outcomes!
Joanna Chikwe, MD, FRCS
Session IV: Update in Cardiac Imaging
Plaque Assessment on CCTA: Is There Clinical Value?
Damini Dey, PhD
Myocardial Blood Flow with PET: Added Clinical Value?
Timothy M. Bateman, MD, FACC
Debate: Is Diagnostic Cath Dead?
Jonathon A. Leipsic, MD, FRCPC
Bruce Samuels, MD, FACC
Session V: Structural Heart Disease
TAVR for Severe Aortic Stenosis After 17 Years: All Risk But Not All Patients
Michael Mack, MD, FACC
Should TAVR Be Standard for Bicuspid Aortic Stenosis, Or Do We Need a Randomized Clinical Trial?
Raj Makkar, MD, FACC
Transcatheter Mitral Valve Repair Should Be the Standard of Care for Functional Mitral Regurgitation
Michael Mack, MD, FACC
Transcatheter Mitral Valve Repair for Functional MR: What Should We Not Get Carried Away?
Sanjay Kaul, MD, MPH, FACC
Thoughts of a Heart Failure Specialist Who Deals with These Patients Every Day
Michele A. Hamilton, MD, FACC
Is Transcatheter Mitral Valve Repair Ready for Low-Risk Patients?
Joanna Chikwe, MD, FRCS
Session VI: Cardioembolic Strokes
Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-Term Prevention of Stroke
Tarun Chakravarty, MD, FACC
Paradigm Shift in Patient Selection for PFO Closure
Matthew J. Price, MD, FACC
Session VII: The Right Ventricle in 2019: Forgotten, But Not Forgiving
The Challenges in RV Function Assessment: Clinical and Imaging Strategies
Siddharth Singh, MD, MS
What to Do When Conventional Therapy for RV Failure is Unsuccessful?
Danny Ramzy, MD, PhD, FACC
GUT Heart Axis: Potential Therapeutic Implications
W.H. Wilson Tang, MD, FACC
Aspirin in Primary Prevention: Who Should Get It?
Sanjay Kaul, MD, MPH, FACC
Targeting ANGPTL3 In Hyperlipidemia
P.K. Shah, MD, MACC
Keynote Lecture: Comprehensive Imaging in Heart Failure
Jeroen Bax, MD, PhD, FACC
Session II: Digital Medicine
Healthcare in the Age of Disruption
Raj Khandwalla, MD, MA, FACC
ACC Initiatives
John G. Harold, MD, MACC
Keynote Lecture: The Hospital Readmission Reduction Policy and Population Health in Heart Failure
Gregg Fonarow, MD, FACC
The Future of Healthcare Delivery
Sachin Jain, MD, FACC
Session III: Controversies in the Treatment of CAD: Expert Views
Complete Versus Incomplete Revascularization in STEMI and MV Disease: Is There Still a Debate?
Shamir Mehta, MD, MSc, FACC
State-of-the-Art: Optimal DAPT Strategies: Lessons Learned, Global Leaders, TWIGHLIGHT, and More
Roxana Mehran, MD, FACC
PCI in Selected Cases: EXCEL, NOBLE and Even Long Term SYNTAXES Show Similar Results
Roxana Mehran, MD, FACC
CABG in All Cases: More Durable, Better Outcomes!
Joanna Chikwe, MD, FRCS
Session IV: Update in Cardiac Imaging
Plaque Assessment on CCTA: Is There Clinical Value?
Damini Dey, PhD
Myocardial Blood Flow with PET: Added Clinical Value?
Timothy M. Bateman, MD, FACC
Debate: Is Diagnostic Cath Dead?
Jonathon A. Leipsic, MD, FRCPC
Bruce Samuels, MD, FACC
Session V: Structural Heart Disease
TAVR for Severe Aortic Stenosis After 17 Years: All Risk But Not All Patients
Michael Mack, MD, FACC
Should TAVR Be Standard for Bicuspid Aortic Stenosis, Or Do We Need a Randomized Clinical Trial?
Raj Makkar, MD, FACC
Transcatheter Mitral Valve Repair Should Be the Standard of Care for Functional Mitral Regurgitation
Michael Mack, MD, FACC
Transcatheter Mitral Valve Repair for Functional MR: What Should We Not Get Carried Away?
Sanjay Kaul, MD, MPH, FACC
Thoughts of a Heart Failure Specialist Who Deals with These Patients Every Day
Michele A. Hamilton, MD, FACC
Is Transcatheter Mitral Valve Repair Ready for Low-Risk Patients?
Joanna Chikwe, MD, FRCS
Session VI: Cardioembolic Strokes
Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-Term Prevention of Stroke
Tarun Chakravarty, MD, FACC
Paradigm Shift in Patient Selection for PFO Closure
Matthew J. Price, MD, FACC
Session VII: The Right Ventricle in 2019: Forgotten, But Not Forgiving
The Challenges in RV Function Assessment: Clinical and Imaging Strategies
Siddharth Singh, MD, MS
What to Do When Conventional Therapy for RV Failure is Unsuccessful?
Danny Ramzy, MD, PhD, FACC
Friday, November 15, 2019
Session VIII: Clinical Electrophysiology
Effective Management of Syncope in 2019
Win Shen, MD, FACC
Debate: Is Atrial Fibrillation Curable?
Atrial Fibrillation is Curable
Michael Shehata, MD, FACC
Once in Atrial Fibrillation, Always in Atrial Fibrillation
Eugenio Cingolani, MD
How to Approach the Patient with Defibrillator Shocks
Ashkan Ehdaie, MD
Session IX: Hypertension
Physician Inertia in Hypertension: Are Pharmacists the Better Doctors?
Florian Rader, MD, MSc, FACC
Keynote Lecture: CT Angiography and FFR-CT To Help Plan Coronary Interventions?
Jonathan Leipsic, MD, FRCPC
Session X: Controversies in Acute PULM Vascular Disease
Acute Intermediate-Risk (Submassive) Pulmonary Embolism Should be Treated with Anticoagulation Plus Aggressive Therapy Such as Catheter-Directed Approaches
• Pro – Victor Tapson, MD
• Con – Oren Friedman, MD
Keynote Lecture: The Perils of Digital Medicine
John Mandrola, MD, FACC
Keynote Lecture: Anticipated Changes in Healthcare Policy Over the Next Few Years
Scott Weingarten, MD, MPH, FACC
Keynote Lecture: Sensationalizing Clinical Trials: ORBITA Trial, A Case in Point
Paul S. Teirstein, MD, FACC
The Physician Entrepreneur: Is There a Role?
Todd Brinton, MD
SESSION XI: New Devices for Heart Failure
Neurostimulation for the Treatment of HFrEF: Vagal Nerve Stimulation, Spinal Cord Stimulation, Renal Denervation, and Baroreflex Activation Therapy
Luanda Grazette, MD, MPH, FACC
Interatrial Shunting for the Treatment of Heart Failure Across the Spectrum of LVEF – HFrEF, HFmrEF, and HFpEF
Neal Eigler, MD, FACC
Session XIII: Controversies in Advanced Heart Failure
Heart Transplantation in 2019: Challenges and Opportunities
Michelle Kittleson, MD, PhD, FACC
Use of RNA Interference (RNAi) Therapies in Cardiac Amyloidosis: Salvation?
Jignesh Patel, MD, PhD, FACC
Debate: Xeno vs. TAH: Which is the Future? Alternatives to Heart Transplantations
• Xenotransplantaton
Lawrence S.C. Czer, MD, FACC
• Total Artificial Heart
Fardad Esmailian, MD
Session XIV: Understanding Pathophysiology of Endurance Sports
Exercise Optimization
Matthew T. Wheeler, MD, PhD
Session XV: Advanced Technology in CVD Management: Improving Outcomes and Quality
The Doctor Will ‘See’ You Now: Incorporating Handheld Ultrasound Into Daily Cardiology Care
Ilan Kedan, MD, MPH, FACC
Effective Management of Syncope in 2019
Win Shen, MD, FACC
Debate: Is Atrial Fibrillation Curable?
Atrial Fibrillation is Curable
Michael Shehata, MD, FACC
Once in Atrial Fibrillation, Always in Atrial Fibrillation
Eugenio Cingolani, MD
How to Approach the Patient with Defibrillator Shocks
Ashkan Ehdaie, MD
Session IX: Hypertension
Physician Inertia in Hypertension: Are Pharmacists the Better Doctors?
Florian Rader, MD, MSc, FACC
Keynote Lecture: CT Angiography and FFR-CT To Help Plan Coronary Interventions?
Jonathan Leipsic, MD, FRCPC
Session X: Controversies in Acute PULM Vascular Disease
Acute Intermediate-Risk (Submassive) Pulmonary Embolism Should be Treated with Anticoagulation Plus Aggressive Therapy Such as Catheter-Directed Approaches
• Pro – Victor Tapson, MD
• Con – Oren Friedman, MD
Keynote Lecture: The Perils of Digital Medicine
John Mandrola, MD, FACC
Keynote Lecture: Anticipated Changes in Healthcare Policy Over the Next Few Years
Scott Weingarten, MD, MPH, FACC
Keynote Lecture: Sensationalizing Clinical Trials: ORBITA Trial, A Case in Point
Paul S. Teirstein, MD, FACC
The Physician Entrepreneur: Is There a Role?
Todd Brinton, MD
SESSION XI: New Devices for Heart Failure
Neurostimulation for the Treatment of HFrEF: Vagal Nerve Stimulation, Spinal Cord Stimulation, Renal Denervation, and Baroreflex Activation Therapy
Luanda Grazette, MD, MPH, FACC
Interatrial Shunting for the Treatment of Heart Failure Across the Spectrum of LVEF – HFrEF, HFmrEF, and HFpEF
Neal Eigler, MD, FACC
Session XIII: Controversies in Advanced Heart Failure
Heart Transplantation in 2019: Challenges and Opportunities
Michelle Kittleson, MD, PhD, FACC
Use of RNA Interference (RNAi) Therapies in Cardiac Amyloidosis: Salvation?
Jignesh Patel, MD, PhD, FACC
Debate: Xeno vs. TAH: Which is the Future? Alternatives to Heart Transplantations
• Xenotransplantaton
Lawrence S.C. Czer, MD, FACC
• Total Artificial Heart
Fardad Esmailian, MD
Session XIV: Understanding Pathophysiology of Endurance Sports
Exercise Optimization
Matthew T. Wheeler, MD, PhD
Session XV: Advanced Technology in CVD Management: Improving Outcomes and Quality
The Doctor Will ‘See’ You Now: Incorporating Handheld Ultrasound Into Daily Cardiology Care
Ilan Kedan, MD, MPH, FACC